Press Release: VIATRIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Viatris Inc. and Encourages Investors to Contact the Firm
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) in the United States District Court for the Western District of Pennsylvania on behalf of all persons…
Press Release: VIATRIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Viatris Inc. and Encourages Investors to Contact the Firm - Newscast
Mon, 28 Apr 2025 04:14:11 GMT With a market cap of $9.1 billion, Viatris Inc. (VTRS) is a global healthcare company with a portfolio of over a thousand approved molecules, including brands like EpiPen, Lipitor, and Viagra, and ...
Fri, 18 Apr 2025 03:45:00 GMT The Company attributed below-expectation guidance on "the expected financial impact from Indore facility warning letter and import alert." Following this news, the price of Viatris' common stock ...
Thu, 17 Apr 2025 10:00:00 GMT On this news, Viatris’ stock price fell $1.71, or 15.2%, to close at $9.53 per share on February 27, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this ...
Thu, 10 Apr 2025 08:36:00 GMT Viatris issued a press release reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics. In addition, Viatris provided lower ...
Sun, 06 Apr 2025 08:00:00 GMT On February 27, 2025, Viatris issued a press release reporting its fourth quarter ... following receipt of a warning letter and import alert from the U.S. Food and Drug Administration, advising ...
